194 related articles for article (PubMed ID: 24076771)
1. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions.
Herfs M; Parra-Herran C; Howitt BE; Laury AR; Nucci MR; Feldman S; Jimenez CA; McKeon FD; Xian W; Crum CP
Am J Surg Pathol; 2013 Sep; 37(9):1311-8. PubMed ID: 24076771
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
Paquette C; Mills AM; Stoler MH
Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
[TBL] [Abstract][Full Text] [Related]
3. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
4. CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials.
Mills AM; Paquette C; Terzic T; Castle PE; Stoler MH
Am J Surg Pathol; 2017 Feb; 41(2):143-152. PubMed ID: 27680604
[TBL] [Abstract][Full Text] [Related]
5. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
6. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
[TBL] [Abstract][Full Text] [Related]
8. Interobserver reproducibility in determining p16 overexpression in cervical lesions : use of a combined scoring method.
Vinyuvat S; Karalak A; Suthipintawong C; Tungsinmunkong K; Kleebkaow P; Trivijitsilp P; Siriaunkgul S; Triratanachat S; Khunamornpong S; Chuangsuwanich T; Settakorn J
Asian Pac J Cancer Prev; 2008; 9(4):653-7. PubMed ID: 19256755
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
10. p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a case series, literature review and commentary.
Huang EC; Tomic MM; Hanamornroongruang S; Meserve EE; Herfs M; Crum CP
Mod Pathol; 2016 Dec; 29(12):1501-1510. PubMed ID: 27515495
[TBL] [Abstract][Full Text] [Related]
11. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
12. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
13. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic dysplasia of the cervix: a newly recognized variant of cervical squamous intraepithelial neoplasia.
Ma L; Fisk JM; Zhang RR; Ulukus EC; Crum CP; Zheng W
Am J Surg Pathol; 2004 Nov; 28(11):1474-84. PubMed ID: 15489651
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?
Lorenzato M; Caudroy S; Bronner C; Evrard G; Simon M; Durlach A; Birembaut P; Clavel C
Hum Pathol; 2005 Oct; 36(10):1101-7. PubMed ID: 16226110
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy.
Kaplan KJ; Dainty LA; Dolinsky B; Rose GS; Carlson J; McHale M; Elkas JC
Cancer; 2004 Aug; 102(4):228-32. PubMed ID: 15368314
[TBL] [Abstract][Full Text] [Related]
19. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
20. Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction.
Herfs M; Somja J; Howitt BE; Suarez-Carmona M; Kustermans G; Hubert P; Doyen J; Goffin F; Kridelka F; Crum CP; Delvenne P
Int J Cancer; 2015 Mar; 136(5):1043-52. PubMed ID: 24839092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]